SIREN : 900712464
LE BRIVET BIO is a French company founded 4 years ago, specialized in the sector Supérettes. Based in SAINTE-ANNE-SUR-BRIVET (44160), this company of category PME shows in 2025 a net income positive of 14 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | N/C | N/C | N/C |
| Net income | 13 996 € | -2 792 € | -137 162 € |
| EBITDA | N/C | N/C | N/C |
| Net margin | N/C | N/C | N/C |
In 2025, LE BRIVET BIO generates positive net income of 14 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
13 996 €
The debt ratio (= Financial debt / Equity x 100) stands at -1915%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
-1915.322%
-4.652%
68.1%
In 2025, the debt ratio of LE BRIVET BIO (-1915.32) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of LE BRIVET BIO (-4.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
The liquidity ratio (= Current assets / Current liabilities) stands at 283.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
283.01
In 2025, the liquidity ratio of LE BRIVET BIO (283.01) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Based on 270 transactions of similar company sales in 2025, the value of LE BRIVET BIO is estimated at 88 147 € (range 35 633€ - 212 060€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 270 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LE BRIVET BIO with other companies in the same sector:
The revenue of LE BRIVET BIO is not publicly disclosed (confidential accounts filed with INPI).
Yes, LE BRIVET BIO generated a net profit of 14 k€ in 2025.
The headquarters of LE BRIVET BIO is located in SAINTE-ANNE-SUR-BRIVET (44160), in the department Loire-Atlantique.
The tax return of LE BRIVET BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LE BRIVET BIO operates in the sector Supérettes (NAF code 47.11C). See the 'Sector positioning' section above to compare the company with its competitors.